Monday, June 15, 2026

Kim Jong Un’s Newest Gamble ‘Capitalism-Lite’: Can the New Law Survive in North Korea?

North Korea's recent Supreme People's Assembly meeting focused on new laws for grain management and intellectual property rights, signaling potential reforms.

MBC Weathercaster’s Tragic Death Stirs Outrage Over Workplace Bullying Allegations

The tragic death of MBC weathercaster Oh Yoanna, allegedly from workplace bullying, has ignited outrage against senior colleagues involved.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

Tag: Lazertinib

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Yuhan to Receive $30 Million Milestone From European Launch of Lazertinib Combination Therapy

Yuhan Corporation receives a $30M milestone for Lazertinib's European launch, totaling $300M in payments, aiming for global healthcare leadership.

Yuhan’s Leclaza and J&J’s Rybrevant: How This Cancer Combo Surged Past 1 Billion USD in Sales

Sales of Yuhan's lung cancer drug 'Lazertinib' and J&J's 'Amivantamab' exceeded 1 trillion won last year.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.